0001209191-18-039681.txt : 20180627 0001209191-18-039681.hdr.sgml : 20180627 20180627170424 ACCESSION NUMBER: 0001209191-18-039681 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180625 FILED AS OF DATE: 20180627 DATE AS OF CHANGE: 20180627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwartz Eric CENTRAL INDEX KEY: 0001329100 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 18922413 MAIL ADDRESS: STREET 1: C/O ERESEARCHTECHNOLOGY, INC. STREET 2: 1818 MARKET STREET, SUITE 1000 CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-25 0 0001237831 GLOBUS MEDICAL INC GMED 0001329100 Schwartz Eric VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 0 1 0 0 Senior VP and General Counsel Class A Common Stock 2018-06-25 4 M 0 10000 24.98 A 10000 D Class A Common Stock 2018-06-25 4 S 0 8444 53.638 D 1556 D Class A Common Stock 2018-06-25 4 S 0 1556 54.594 D 0 D Stock Option (Right to Buy Class A Common Stock) 24.98 2018-06-25 4 M 0 10000 0.00 D 2026-04-28 Class A Common Stock 10000 41000 D This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.24 to $54.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.29 to $54.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. These options were included in a grant of 75,000 options that was granted on May 3, 2016, and which vests over a four-year period with one-fourth (1/4) of the options granted vesting on April 28, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. /s/ Eric I. Schwartz 2018-06-27